These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 998471)

  • 1. Amikacin.
    Gleckman R
    Am Fam Physician; 1976 Dec; 14(6):75. PubMed ID: 998471
    [No Abstract]   [Full Text] [Related]  

  • 2. Resistance to aminoglycoside antibiotics of gram-negative bacilli isolated in Canadian hospitals.
    Duncan IB; Cheung EY; Haldane EV; Jackson FL; McNaughton RD; Morisset RA; Noble MA; Rennie RP; Ronald AR; Smith JA
    Can Med Assoc J; 1981 May; 124(9):1165-7. PubMed ID: 7237336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical pharmacology of the most frequently used aminoglucosides: gentamycin, tobramycin and amikacin].
    Cuena Boy R; Azanza Perea JR; Echeverría Echepare LM; Honorato Pérez J
    Rev Med Univ Navarra; 1983 Dec; 27(4):21-7. PubMed ID: 6676898
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical and microbiologic consequences of amikacin use during a 42-month period.
    Berk SL; Alvarez S; Ortega G; Verghese A; Holtsclaw-Berk SA
    Arch Intern Med; 1986 Mar; 146(3):538-41. PubMed ID: 3954526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid development of resistance of gentamicin, tobramycin and amikacin by E. coli 07.
    Humble MW; Bettelheim KA
    N Z Med J; 1978 May; 87(612):366. PubMed ID: 353599
    [No Abstract]   [Full Text] [Related]  

  • 6. Gentamicin-resistant gram-negative bacilli in hospital patients. Part II. In vitro aspects including susceptibility to tobramycin and amikacin.
    Block CS; Fabian B; Robinson RG
    S Afr Med J; 1978 Mar; 53(11):396-99. PubMed ID: 675374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Amikacin in the treatment of Gram negative bacilli septicemias].
    Cartier F; Dien G; Cormier M; Hoel JC; Guivarch G
    Nouv Presse Med; 1979 Oct; 8(42):3510-12. PubMed ID: 537908
    [No Abstract]   [Full Text] [Related]  

  • 8. [Distribution of aminoside resistance in 430 strains of gram-negative bacilli in a hospital environment. Value of amikacine].
    Le Noc P; Croizé J
    Sem Hop Ther; 1977; 53(7-8):378-83. PubMed ID: 244369
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical and bacteriological evaluation of Amikin (Amikacin sulfate) by Bristol-Myers].
    Wencel J; Czaplicki M; Borkowski A; Malewski AW
    Pol Tyg Lek; 1978 Dec; 33(50):1937-8. PubMed ID: 733620
    [No Abstract]   [Full Text] [Related]  

  • 10. Laboratory and clinical studies on amikacin.
    Wang QN; Du JZ; Liu YH; Jiang YF; Sheng JQ; Qiu ZD; Luo MY
    Chin Med J (Engl); 1985 Nov; 98(11):807-16. PubMed ID: 3938711
    [No Abstract]   [Full Text] [Related]  

  • 11. [Topical and microbiological evaluation of dideoxykanamycin B in comparison to other second and third generation aminoglycosides].
    Nicoletti G; Russo G; Toscano MA; Gismondo MR; Mattina R
    G Ital Chemioter; 1979; 26(1-2):167-72. PubMed ID: 554806
    [No Abstract]   [Full Text] [Related]  

  • 12. [Control of the resistance of gram-negative bacilli to aminoglucosides. Results of a 3-year prospective study with the exclusive use of amikacin].
    Ruiz-Palacios G; Ponce de León S; Sifuentes J; Ponce de León S; Calva J; Huazano F; Ontiveros C; Ojeda F; Bobadilla M
    Rev Invest Clin; 1986; 38(1):1-6. PubMed ID: 3738260
    [No Abstract]   [Full Text] [Related]  

  • 13. Transduction of amikacin, gentamicin and tobramycin resistance in Pseudomonas aeruginosa.
    Knothe H; Krcméry V; Mitsuhashi S
    Zentralbl Bakteriol A; 1980 Mar; 246(3):373-8. PubMed ID: 6775445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New aminoglycoside antibiotics].
    Dzierzanowska D
    Pol Tyg Lek; 1977 Sep; 32(38):1483-6. PubMed ID: 905200
    [No Abstract]   [Full Text] [Related]  

  • 15. Amikacin: in vitro bacteriological studies, levels in human serum, lung and heart tissue, and clinical results.
    Faragó E; Kiss J; Gömöry A; Aranyosi J; Juhász I; Mihóczy L
    Int J Clin Pharmacol Biopharm; 1979 Nov; 17(11):421-8. PubMed ID: 511416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Amikacin in the treatment of hospital infections of the urinary tract caused by gram-negative bacilli resistant to gentamicin. Microbiological and clinical aspects].
    Romoli E; Di Leonardo F; Giordano G; De Felice M; Cerquetti F; Vonmoos A
    Minerva Urol; 1981; 33(2):85-90. PubMed ID: 7322100
    [No Abstract]   [Full Text] [Related]  

  • 17. Controlled comparison of amikacin and gentamicin.
    Smith CR; Baughman KL; Edwards CQ; Rogers JF; Lietman PS
    N Engl J Med; 1977 Feb; 296(7):349-53. PubMed ID: 319355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro susceptibility of gram negative bacteria to amikacin and its comparison with three other aminoglycoside antibiotics.
    Daniel J; Thomas M; Shanmugam J
    Indian J Pathol Microbiol; 1985 Apr; 28(2):115-9. PubMed ID: 3835114
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative study and time changes in the resistance to gentamycin, tobramycin, sisomicin and amikacin of Gram-negative nosocomial bacterial strains isolated from the urinary tract, in relation to the annual use of the aminoglycosides tested].
    Alegente G; Marchi B; Pieri I; Saturni A; Progenie G; Rubino M
    Quad Sclavo Diagn; 1983 Sep; 19(3):343-8. PubMed ID: 6677931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amikacin therapy of severe infections produced by gram-negative bacilli resistant to gentamicin.
    Valdivieso M; Bodey GP
    Am J Med Sci; 1977; 273(2):177-84. PubMed ID: 860733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.